Presence of known feline ALMS1 and MYBPC3 variants in a diverse cohort of cats with hypertrophic cardiomyopathy in Japan
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0283433 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Noriyoshi Akiyama und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research and Developmental Division, Anicom Insurance Inc., Yokohama, Kanagawa, Japan. Hauptthemen laut MEDLINE: Carrier Proteins, Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Foundation of Anicom Insurance Inc., Anicom Specialty Medical Institute Inc., Anicom Pafe Inc..
Abstract (Originalsprache)
Hypertrophic cardiomyopathy (HCM) is the most common heart disease in cats with a suspected genetic origin. Previous studies have identified five HCM-associated variants in three genes (Myosin binding protein C3: MYBPC3 p.A31P, p.A74T, p.R820W; Myosin heavy chain 7: MYH7 p.E1883K; Alstrom syndrome protein 1: ALMS1 p.G3376R). These variants are considered breed-specific, with the exception of MYBPC3 p.A74T, and have rarely been found in other breeds. However, genetic studies on HCM-associated variants across breeds are still insufficient because of population and breed bias caused by differences in genetic background. This study investigates the ubiquitous occurrence of HCM-associated genetic variants among cat breeds, using 57 HCM-affected, 19 HCM-unaffected, and 227 non-examined cats from the Japanese population. Genotyping of the five variants revealed the presence of MYBPC3 p.A31P and ALMS1 p.G3376R in two (Munchkin and Scottish Fold) and five non-specific breeds (American Shorthair, Exotic Shorthair, Minuet, Munchkin and Scottish Fold), respectively, in which the variants had not been identified previously. In addition, our results indicate that the ALMS1 variants identified in the Sphynx breed might not be Sphynx-specific. Overall, our results suggest that these two specific variants may still be found in other cat breeds and should be examined in detail in a population-driven manner. Furthermore, applying genetic testing to Munchkin and Scottish Fold, the breeds with both MYBPC3 and ALMS1 variants, will help prevent the development of new HCM-affected cat colonies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research and Developmental Division, Anicom Insurance Inc., Yokohama, Kanagawa, Japan.
- Genetic Testing Section, Anicom Pafe Inc., Yokohama, Kanagawa, Japan.
- Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Medicine, School of Veterinary Medicine, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, Musashino, Tokyo, Japa…
- Data Science center, Azabu University, Sagamihara, Kanagawa, Japan.
ORCID-Profile: Noriyoshi Akiyama, Yunosuke Yuchi, Yuki Matsumoto
Förderung
- Research Foundation of Anicom Insurance Inc.
- Anicom Specialty Medical Institute Inc.
- Anicom Pafe Inc.
- Nippon Veterinary and Life Science University
- Azabu University
Zitieren
APA
Akiyama, N., Suzuki, R., Saito, T., Yuchi, Y., Ukawa, H., & Matsumoto, Y. (2023). Presence of known feline ALMS1 and MYBPC3 variants in a diverse cohort of cats with hypertrophic cardiomyopathy in Japan. PLOS ONE. https://doi.org/10.1371/journal.pone.0283433
Vancouver
Akiyama N, Suzuki R, Saito T, Yuchi Y, Ukawa H, Matsumoto Y. Presence of known feline ALMS1 and MYBPC3 variants in a diverse cohort of cats with hypertrophic cardiomyopathy in Japan. PLOS ONE. 2023. doi:10.1371/journal.pone.0283433
BibTeX
@article{Akiyama2023,
author = {Akiyama, Noriyoshi and Suzuki, Ryohei and Saito, Takahiro and Yuchi, Yunosuke and Ukawa, Hisashi and Matsumoto, Yuki},
title = {Presence of known feline ALMS1 and MYBPC3 variants in a diverse cohort of cats with hypertrophic cardiomyopathy in Japan},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0283433}
}
EUVIMED